TScan Therapeutics, Inc. logo

TScan Therapeutics, Inc.

TCRXNASDAQ

TScan Therapeutics, Inc. is a biotechnology company in the healthcare sector on NASDAQ, led by Gavin MacBeath, with a market cap of $57.3M. As of Q3 2025, 61% of shares are held by 72 institutional investors, with Lynx1 Capital Management LP as the largest holder at 13.85%.

Chief Executive OfficerGavin MacBeath
Market Cap$57.3M
Biotechnology
Healthcare
Employees154.0
Websitetscan.com
Country
United States of America

Overview

Overview of institutional ownership in TCRX as of Q3 2025 with a market cap of $103.3M

All Institutions

Institutions
72
Value Held
$62.9M
Shares Held
34.6M
Avg Position
$873.8K
Median Position
$86.0K

Hedge Funds

Hedge Funds
11
Value Held
$27.6M
Shares Held
15.1M
Avg Position
$2.5M
Median Position
$763.3K

Ownership Breakdown

Institutional (non-HF): 34.22%Institutional (non-HF)Hedge Funds: 26.69%Hedge FundsRetail & Other: 39.09%Retail & Other
Institutional (non-HF)
34.22%
$35.3M
Hedge Funds
26.69%
$27.6M
Retail & Other
39.09%
$40.4M

Based on market cap of $103.3M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.

Biggest Investors

Institutions with the largest positions in TCRX as of Q3 2025

InstitutionPosition Value
L
Lynx1 Capital Management LP
Hedge FundSector
$14.3M
2.91% of portfolio
B
BVF INC/IL
Institution
$9.5M
0.39% of portfolio
B
BAKER BROS. ADVISORS LP
Hedge FundSector
$5.1M
0.05% of portfolio
B
BlackRock, Inc.
Institution
$4.3M
0.00% of portfolio
$4.2M
0.00% of portfolio
Propel Bio Management, LLC logo
Propel Bio Management, LLC
Hedge FundSector
$3.5M
3.52% of portfolio
$2.5M
0.00% of portfolio
$2.3M
0.20% of portfolio
Alphabet Inc. logo
Alphabet Inc.
Institution
$2.0M
0.08% of portfolio
$1.6M
0.10% of portfolio

Net Capital Flow

Institutional buying and selling activity for TCRX in Q3 2025

Traded
$1.2M
Buyers
24
Sellers
40
Total Bought
+$2.2M
Total Sold
$3.3M
Avg Position
$748.9K

Biggest Buyers

InstitutionNet Bought
+$843.3K
+463.4K shares
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
+$312.6K
+171.8K shares
+$306.7K
+168.5K shares
TWO SIGMA ADVISERS, LLC logo
TWO SIGMA ADVISERS, LLC
Hedge FundMulti-Strategy
+$135.4K
+74.4K shares
TWO SIGMA INVESTMENTS LLC logo
TWO SIGMA INVESTMENTS LLC
Hedge FundMulti-Strategy
+$99.0K
+54.4K shares
+$89.3K
+49.1K shares
+$87.1K
+47.9K shares
+$68.9K
+37.9K shares
+$62.4K
+34.2K shares
L
+$39.1K
+21.5K shares

Biggest Sellers

InstitutionNet Sold
$544.3K
299.1K shares
B
BlackRock, Inc.
Institution
$334.4K
183.8K shares
MILLENNIUM MANAGEMENT LLC logo
MILLENNIUM MANAGEMENT LLC
Hedge FundMulti-Strategy
$298.6K
164.1K shares
Propel Bio Management, LLC logo
Propel Bio Management, LLC
Hedge FundSector
$281.8K
154.8K shares
$258.3K
141.9K shares
$240.4K
132.1K shares
$237.4K
130.4K shares
T
Troluce Capital Advisors LLC
Hedge FundMulti-Strategy
$217.5K
150.0K shares
$117.6K
64.6K shares
Y
Y-Intercept Ltd
Institution
$111.2K
76.7K shares

Entry and Exit Activity

Institutions that initiated new positions or completely exited TCRX in Q3 2025

New Positions
2
New Value
$87.5K
Exited Positions
11
Exited Value
$631.8K

New Positions

InstitutionPosition Value
$87.1K
47.9K shares
$364.0
200.0 shares

Exited Positions

InstitutionPrevious Position
T
Troluce Capital Advisors LLC
Hedge FundMulti-Strategy
$217.5K
150.0K shares
Y
Y-Intercept Ltd
Institution
$111.2K
76.7K shares
H
$80.3K
55.4K shares
Jain Global LLC logo
Jain Global LLC
Hedge FundMulti-Strategy
$54.9K
37.9K shares
$35.3K
24.4K shares
S
Squarepoint Ops LLC
Hedge FundQuant
$32.6K
22.5K shares
AQR CAPITAL MANAGEMENT LLC logo
AQR CAPITAL MANAGEMENT LLC
Hedge FundMulti-Strategy
$32.5K
22.4K shares
$32.1K
22.2K shares
$20.1K
13.9K shares
$14.7K
10.1K shares

Options Activity

Institutions with the largest Call and Put options positions in TCRX as of Q3 2025

Call Positions
0
Call Value
-
Put Positions
0
Put Value
-

Call Positions

InstitutionPosition Value
No call positions found

Put Positions

InstitutionPosition Value
No put positions found

Most Committed Institutions

Institutions with TCRX as the highest % of their portfolio as of Q3 2025

InstitutionPortfolio Weight
D
DC Funds, LP
Institution
36.87%
$1.1M
Propel Bio Management, LLC logo
Propel Bio Management, LLC
Hedge FundSector
3.52%
$3.5M
L
Lynx1 Capital Management LP
Hedge FundSector
2.91%
$14.3M
B
BVF INC/IL
Institution
0.39%
$9.5M
0.20%
$2.3M
0.10%
$1.6M
Militia Capital Partners, LP logo
Militia Capital Partners, LP
Hedge FundLong/Short
0.09%
$185.8K
Alphabet Inc. logo
Alphabet Inc.
Institution
0.08%
$2.0M
B
BAKER BROS. ADVISORS LP
Hedge FundSector
0.05%
$5.1M
0.04%
$1.1M

Hedge Fund Spotlight

Discover hedge funds investing in TCRX

Militia Capital Partners, LP logo
Militia Capital Partners, LP
Hedge FundLong/Short
Portfolio Value
$195.8M
Positions
153
Last Reported
Q3 2025
AddressLas Vegas, NV
Sector Allocation
Financial Services: 16.20%Financial ServicesEnergy: 15.40%EnergyTechnology: 14.60%TechnologyIndustrials: 11.70%IndustrialsHealthcare: 7.80%HealthcareETF: 6.60%Consumer Cyclical: 5.80%Real Estate: 3.10%Communication Services: 3.10%Consumer Defensive: 2.70%Basic Materials: 0.70%Utilities: 0.20%
TScan Therapeutics, Inc. logo

Position in TScan Therapeutics, Inc.

Market Value
$185.8K
Shares Held
102.1K
Portfolio Weight
0.09%
Owned Since
2025-Q2
Top HoldingSectorMarket ValueWeight
Unknown
Unknown
$8.6M4.40%
2
Amazon logo
Amazon
AMZN
Specialty Retail
Consumer Cyclical
$8.3M4.22%
Oil & Gas Midstream
Energy
$8.2M4.18%

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.